Oral hydrogen water prevents chronic allograft nephropathy in rats

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 64, Issue 6, Pages (December 2003)
Volume 66, Issue 1, Pages (July 2004)
Volume 74, Issue 11, Pages (December 2008)
Volume 77, Issue 9, Pages (May 2010)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 67, Issue 5, Pages (May 2005)
Volume 78, Issue 3, Pages (August 2010)
Volume 81, Issue 11, Pages (June 2012)
Volume 78, Issue 11, Pages (December 2010)
Volume 84, Issue 5, Pages (November 2013)
Volume 76, Issue 1, Pages (July 2009)
Volume 91, Issue 2, Pages (February 2017)
Volume 66, Issue 3, Pages (September 2004)
Volume 79, Issue 10, Pages (May 2011)
A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome  Gerhard C. Hildebrandt, Krystyna.
Volume 73, Issue 3, Pages (February 2008)
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 78, Issue 10, Pages (November 2010)
Volume 82, Issue 8, Pages (October 2012)
Volume 82, Issue 1, Pages (July 2012)
IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft- Versus-Host Disease  Doanh Le Huu, Takashi Matsushita, Guihua Jin, Yasuhito.
Volume 79, Issue 6, Pages (March 2011)
Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non–heart-beating donors  Boming Dong, MD, PhD, Paul.
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 74, Issue 11, Pages (December 2008)
Volume 88, Issue 3, Pages (September 2015)
Volume 75, Issue 10, Pages (May 2009)
Volume 82, Issue 10, Pages (November 2012)
Volume 63, Issue 4, Pages (April 2003)
Volume 87, Issue 2, Pages (February 2015)
Mechanisms of the proteinuria induced by Rho GTPases
Volume 53, Issue 6, Pages (June 1998)
Volume 84, Issue 4, Pages (October 2013)
Volume 79, Issue 5, Pages (March 2011)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 54, Issue 6, Pages (January 1998)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 81, Issue 3, Pages (February 2012)
Carbon monoxide–saturated preservation solution protects lung grafts from ischemia– reperfusion injury  Junichi Kohmoto, MD, Atsunori Nakao, MD, Ryujiro.
Decreased renal ischemia–reperfusion injury by IL-16 inactivation
Volume 79, Issue 1, Pages (January 2011)
Volume 81, Issue 5, Pages (March 2012)
Volume 80, Issue 12, Pages (December 2011)
Volume 82, Issue 3, Pages (August 2012)
Volume 64, Issue 4, Pages (October 2003)
Volume 82, Issue 4, Pages (August 2012)
Volume 63, Issue 2, Pages (February 2003)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 69, Issue 2, Pages (January 2006)
Volume 79, Issue 10, Pages (May 2011)
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 56, Issue 3, Pages (September 1999)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 85, Issue 4, Pages (April 2014)
Volume 66, Issue 1, Pages (July 2004)
Volume 67, Issue 5, Pages (May 2005)
Volume 79, Issue 2, Pages (January 2011)
Volume 64, Issue 3, Pages (September 2003)
Volume 74, Issue 11, Pages (December 2008)
Volume 61, Issue 1, Pages (January 2002)
Acute renal failure: From renal physiology to the renal transcriptome
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 3, Pages (March 2004)
Volume 74, Issue 8, Pages (October 2008)
Hideki Itano, MDa, Bassem N. Mora, MDa, Wanjiang Zhang, MDa, Jon H
Presentation transcript:

Oral hydrogen water prevents chronic allograft nephropathy in rats Jon S. Cardinal, Jianghua Zhan, Yinna Wang, Ryujiro Sugimoto, Allan Tsung, Kenneth R. McCurry, Timothy R. Billiar, Atsunori Nakao  Kidney International  Volume 77, Issue 2, Pages 101-109 (January 2010) DOI: 10.1038/ki.2009.421 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Hydrogen water (HW) administration improves kidney allograft function. (a) Hydrogen-rich water (HW) (3 ml) was orally administered to naïve Lewis (LEW) rats by gavage. Arterial blood and kidney tissue were taken at 15, 30, and 60 min after oral administration of HW. Hydrogen concentration in blood and homogenized kidney tissue increased within 15 min and then returned to the basal levels (n=3). (*P<0.05 vs 0 min). (b) Kinetic analysis of the blood hydrogen levels after HW (3 ml) administration in the transplanted recipients that had been given HW for 60 days were performed. Both isograft recipients (n=3) and allograft recipients (n=3) showed similar changes in circulating hydrogen concentrations. (c) Male LEW rats were used as donors for either syngeneic (LEW recipient) or allogeneic (Brown Norway recipient) renal transplantation. Recipients were given either regular water (RW) or HW ad libitum after transplantation, resulting in a total of four experimental groups: isograft given RW (Iso/RW, n=8) or HW (Iso/HW, n=8); or allograft given RW (Allo/RW, n=18) or HW (Allo/HW, n=17). The recipients receiving daily HW had improved allograft function, as measured by blood urea nitrogen (BUN), creatinine clearance (CCr), and 24 h urinary protein excretion, as compared with those receiving RW at 60 days posttransplantation. (*P<0.05 vs Allo/RW). Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Hydrogen water (HW) administration improves long-term survival after kidney allotransplantation. (a) Although isograft recipients showed fair body weight gains regardless of intake of HW, the recipients with allografts given regular water (RW) gradually lost body weight by 60–80 days after transplantation. The recipients given HW showed better body weight gain compared with those without HW. (b) In correlation with improved graft function, survival of allograft recipients was significantly prolonged with oral administration of HW. (Isograft given RW (Iso/RW), (n=5); isograft given HW (Iso/HW), (n=5); allograft given RW (Allo/RW) (n=13); allograft given HW (Allo/HW) (n=12); Kaplan-Meier, log-rank test, P<0.05 Allo/RW vs Allo/HW). Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Hydrogen water (HW) administration decreases chronic allograft nephropathy after kidney allotransplantation. Hematoxylin/eosin (a), Masson's trichome (b), or α-smooth muscle actin (c) staining was performed 60 days posttransplantation to assess histological and/or immunohistochemical evidence of chronic allograft nephropathy. Images are representative of four separate, individual grafts from each experimental group. Original magnification × 200. Allo/HW, allograft given HW; Allo/RW, allograft given RW; RW, regular water. Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Hydrogen water (HW) administration decreases intragraft inflammatory cell infiltration after kidney allotransplantation. CD3-positive (a) and CD68-positive (b) infiltrating cells were assessed by immunohistochemistry and quantitated as number of positive-staining cells per high-power field (HPF) (original magnification × 400) (c). Images are representative of five individual animals for each group; (n=5 for each group, original magnification × 200, *P<0.05 versus Allo/RW). Allo/HW, allograft given HW; Allo/RW, allograft given RW; Iso HW, isograft given HW; Iso RW, isograft given RW; RW, regular water. Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Hydrogen water (HW) administration decreases intragraft markers of oxidative stress after kidney allotransplantation. (a) Intragraft malondialdehyde (MDA) levels were quantitated using a commercially available kit. MDA levels in the allografts treated with regular water (RW) increased 60 days after transplantation. HW significantly reduced tissue MDA levels. (n=5, *P<0.05 vs Allo/RW). In addition, immunohistochemistry for 4-hydroxy-2-nonenal (HNE) (b) and peroxynitrite (c) was performed on formalin-fixed sections obtained from the allograft groups. Oxidative injuries were more prominent in the allografts given RW (Allo/RW) compared with those given HW (Allo/HW). Arrows indicate HNE-positive cells. (Original magnification × 400; images are representative of three separate experiments). Allo/HW, allograft given HW; Allo/RW, allograft given RW; Iso HW, isograft given HW; Iso RW, isograft given RW. Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Hydrogen water (HW) administration decreases the intragraft production of inflammatory cytokines after kidney allotransplantation. Interleukin-6 (IL-6) tumor necrosis factor-α (TNFα) intracellular adhesion molecule-1 (ICAM-1), and interferon-γ (IFNγ) mRNA levels in the kidney grafts taken 60 days after transplant were measured by real-time quantitative reverse transcriptase PCR analysis. Although allograft rejection caused upregulation of the mRNAs for these markers, HW significantly reduced the mRNA levels as compared with regular water (RW). (n=5, *P<0.05 vs Allo/RW). Allo HW, allograft given HW; Allo RW, allograft given RW; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Iso HW, isograft given HW; Iso RW, isograft given RW. Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 Hydrogen water (HW) administration decreases intragraft inflammatory signaling cascade activation after kidney allotransplantation. Western blot analysis showed that mitogen-activated protein (MAP) kinases (JNK (c-Jun NH 2-terminal kinase), p38, ERK1/2 (extracellular signal-regulated kinase 1/2)) and upstream kinase cascades (MEK-1), were less activated in allografts obtained from recipients that were HW-treated compared with those obtained from regular water (RW)-treated recipients. Images are representative of three independent experiments. Allo, allograft recipients; Iso, isograft recipients; p, phosphorylated; t, total. Kidney International 2010 77, 101-109DOI: (10.1038/ki.2009.421) Copyright © 2010 International Society of Nephrology Terms and Conditions